Tenofovir (TDF) HIV Drug Lawsuit

On This Page
Lawsuit Overview
Biotechnology company Gilead Sciences, Inc. is embroiled in litigation concerning its HIV treatment drugs, such as Truvada® and other tenofovir disoproxyl fumurate (TDF) drugs. TDF drugs are linked to severe side-effects such as chronic kidney disease, bone density loss and fracturing. The company is being sued over accusations that it withheld a safer alternative to TDF to reap profits from booming sales. Lawsuits allege that as early as 2001, Gilead knew of the harmful side effects of its TDF drugs but withheld the safer alternative, tenofovir alafenamide (TAF) despite the risks. Gilead’s TDF drugs include:- Truvada®
- Viread®
- Atripla®
- Complera®
- Stribild®